Clinical Trials · NCT05164614

Study Evaluating PK of PTH Administered Orally Via RaniPill™ Capsule

CompletedPhase 1Teriparatide (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
RANI Therapeutics
Enrollment
50
Start date
Feb 2022
Locations
1 site, Australia
Primary endpoint
Evaluate Cmax of PTH administered via the RaniPill capsule
View Teriparatide compound reference